FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024841180> ?p ?o ?g. }

• W2024841180 endingPage "185" @default.
• W2024841180 startingPage "184" @default.
• W2024841180 abstract "Carcinomatous pleuritis in patients with lung cancer is usually found to accompany frank malignant pleural effusion and is associated with short-term survival.1Sugiura S Ando Y Minami H Ando M Sakai S Shimokata K Prognostic value of pleural effusion in patients with non–small cell lung cancer.Clin Cancer Res. 1997; 3: 47-50PubMed Google Scholar However, this condition is sometimes discovered, with or without a small amount of pleural effusion, at thoracotomy in patients with resectable non–small cell lung cancer. The incidence is reported as 3.2%,2Ichinose Y Tsuchiya R Koike T Kuwahara O Nakagawa K Yamato Y et al.Prognosis of resected non–small cell lung cancer patients with carcinomatous pleuritis of minimal disease.Lung Cancer. 2001; 32: 55-60Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar and in such patients surgical treatment has been applied in some institutions, with long-term survival in selected cases. We report here the results of extrapleural pneumonectomy for patients with lung cancer with carcinomatous pleuritis and discuss surgical treatment for this disease. Between January 1988 and December 1999, a total of 602 patients underwent exploration for the resection of primary lung cancer at our hospital. Among the patients, 11 (1.7%) underwent an extrapleural pneumonectomy with lymph node dissection because of carcinomatous pleuritis. Extrapleural pneumonectomy was performed in patients who had pleural disseminated tumors with or without a minimal effusion (<300 mL) and an adequate cardiopulmonary reserve. Patients with massive malignant pleural effusions were excluded from surgical candidacy. All the patients gave written informed consent for the operation. The details of the operative procedure were described in our previous case report.3Yokoi K Miyazawa N Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.Eur J Cardiothorac Surg. 1996; 10: 141-143Crossref PubMed Scopus (13) Google Scholar All patients underwent excision of the pericardium and complete removal of the hemidiaphragm. The pericardium and diaphragm were usually reconstructed with synthetic membranes. Data are reported as means ± SD. Survival was measured from the operation until death or the last date of follow-up (April 30, 2001), and the data are reported as means and 95% confidence intervals (CI) for the mean. The Kaplan-Meier method was used to calculate actuarial survival. The demographics of these 11 patients (9 women and 2 men) are shown in Table 1.Table 1Patients with lung cancer who underwent an extrapleural pneumonectomy for carcinomatous pleuritisPatient No. (age [y], sex)StageOperationRecurrenceSurvival after operation (mo)ClinicalPathologicTime (min)Blood loss (g)Disease freeOverall 1 (44, F)T2 N0T4 N14301300—149149; alive without disease 2 (41, F)T1 N0T4 N0510323—8787; alive without disease 3 (58, M)T4 N2T4 N2495980Pericardial effusion679; died of disease 4 (49, F)T4 N2T4 N2520600Supraclavicular lymph nodes1425; alive with disease 5 (62, F)T2 N0T4 N0470700UnknownUnknown20; died of disease 6 (49, F)T4 N0T4 N0464297—2020; alive without disease 7 (49, F)T4 N0T4 N0361452—2020; alive without disease 8 (70, F)T4 N0T4 N2407539Skin719; died of disease 9 (33, M)T4 N0T4 N2535896Bone411; died of disease10 (61, F)T3 N2T4 N1473660—66; died of other cause11 (43, F)T4 N0T4 N2445850UnknownUnknown6; died of disease Open table in a new tab The mean age at operation was 50.8 ± 10.9 years (range, 33-70 years). The most common symptoms were chest pain in 3 patients and cough, dyspnea, and general fatigue in 1 patient each. Five patients were free of symptoms. Histologic examination, cytologic examination, or both, of the specimen obtained from the intrapulmonary mass with a fiberoptic bronchoscope or by percutaneous transthoracic needle biopsy showed adenocarcinoma in 10 patients. Only the eleventh patient, whose pulmonary nodule was undetectable before the operation, underwent pleural biopsy, but it was not known whether the lesion originated from lung adenocarcinoma or malignant pleural mesothelioma. All patients underwent chest computed tomographic scanning to determine clinical staging. Carcinomatous pleuritis was suspected preoperatively in 7 patients; pleural disseminated nodules were observed on computed tomographic scanning in 5 patients, and malignant pleural effusion was detected in 2 patients. However, the remaining 4 patients were given diagnoses of T1, T2, or T3 tumors, and their disease conditions were found at thoracotomy. Preoperative chemotherapy was performed in only the fourth patient with N2 disease. In all patients pathologic examination, including immunohistochemical analysis of the resected specimen, revealed that the primary tumor was lung adenocarcinoma, and the pleural disseminated nodules were compatible with the intrapulmonary lesion. The operation time was 464.5 ± 51.7 minutes, and blood loss during the operation was 690.6 ± 300.3 g. The final pathologic stage was T4 N0 in 4 patients, T4 N1 in 2 patients, and T4 N2 in 5 patients. All patients survived the operation and were discharged from the hospital. Complications were intrathoracic hemorrhage and empyema without bronchopleural fistula in 1 patient each. Postoperative radiotherapy was performed in the third and tenth patients, and chemotherapy was performed in the first patient. Follow-up data were complete for all patients. The 5-year and 10-year survivals of all the patients were 54.5% (95% CI, 25.1%-84.0%) and 36.4% (95% CI, 1.3%-71.5%), respectively. Among the 6 patients with pathologic N0-1 disease, 4 patients are alive without disease 20 to 146 months after operation, and the 5-year survival was 66.7% (95% CI, 28.9%-100%). Of the 5 patients with N2 disease, all had recurrent disease, and there was only 1 long-term survivor in whom malignant pericardial effusion developed 6 months after the operation. Non–small cell lung cancer with carcinomatous pleuritis is generally considered to be a contraindication for surgical treatment and is associated with a poor outcome.1Sugiura S Ando Y Minami H Ando M Sakai S Shimokata K Prognostic value of pleural effusion in patients with non–small cell lung cancer.Clin Cancer Res. 1997; 3: 47-50PubMed Google Scholar However, some surgeons have continued to perform a resection for selected patients with the disease.2Ichinose Y Tsuchiya R Koike T Kuwahara O Nakagawa K Yamato Y et al.Prognosis of resected non–small cell lung cancer patients with carcinomatous pleuritis of minimal disease.Lung Cancer. 2001; 32: 55-60Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar, 3Yokoi K Miyazawa N Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.Eur J Cardiothorac Surg. 1996; 10: 141-143Crossref PubMed Scopus (13) Google Scholar, 4Reyes L Parvez Z Regal A-M Takita H Neoadjuvant chemotherapy and operations in the treatment of lung cancer with pleural effusion [letter].J Thorac Cardiovasc Surg. 1991; 101: 946-947PubMed Google Scholar The Japan Clinical Oncology Group reported that the 5-year survival of patients undergoing resection for minimal carcinomatous pleuritis was 22.8%, and being female and having a clinical N0 stage were significantly good prognostic factors.2Ichinose Y Tsuchiya R Koike T Kuwahara O Nakagawa K Yamato Y et al.Prognosis of resected non–small cell lung cancer patients with carcinomatous pleuritis of minimal disease.Lung Cancer. 2001; 32: 55-60Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar Extrapleural pneumonectomy has been used by thoracic surgeons in the treatment of diffuse malignant pleural mesothelioma, as well as other pleural diseases, such as tuberculus empyema. The efficacy of this procedure has been suggested in managing patients with malignant pleural mesothelioma localized in the hemithorax.5Sugarbaker DJ Garcia JP Richards WG Harpole Jr, DH Healy-Baldini E DeCamp Jr, MM et al.Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients.Ann Surg. 1996; 224: 288-296Crossref PubMed Scopus (196) Google Scholar In this study our patients had lung adenocarcinoma and pleural disseminated nodules with or without a small amount of malignant effusion, which was compatible with minimal disease described by the Japan Clinical Oncology Group2Ichinose Y Tsuchiya R Koike T Kuwahara O Nakagawa K Yamato Y et al.Prognosis of resected non–small cell lung cancer patients with carcinomatous pleuritis of minimal disease.Lung Cancer. 2001; 32: 55-60Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar and might be a localized disease in the hemithorax. Extrapleural pneumonectomy with lymph node dissection was performed safely in all patients and resulted in a good long-term survival, especially in female patients without pathologic N2 disease. Our results indicate that carefully selected patients with carcinomatous pleuritis may be candidates for extrapleural pneumonectomy for cure. Nevertheless, the ultimate value of this surgical treatment should be ascertained in a prospective study with a large number of patients because our results may have been affected by the nature of the tumors, such as the slow-growing tumor noted in the third patient." @default.
• W2024841180 created "2016-06-24" @default.
• W2024841180 creator A5010073174 @default.
• W2024841180 creator A5030798280 @default.
• W2024841180 creator A5057478088 @default.
• W2024841180 date "2002-01-01" @default.
• W2024841180 modified "2023-10-14" @default.
• W2024841180 title "Extrapleural pneumonectomy for lung cancer with carcinomatous pleuritis" @default.
• W2024841180 cites W2027384041 @default.
• W2024841180 cites W2098614275 @default.
• W2024841180 cites W2102403327 @default.
• W2024841180 cites W2402560161 @default.
• W2024841180 doi "https://doi.org/10.1067/mtc.2002.118039" @default.
• W2024841180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11782773" @default.
• W2024841180 hasPublicationYear "2002" @default.
• W2024841180 type Work @default.
• W2024841180 sameAs 2024841180 @default.
• W2024841180 citedByCount "31" @default.
• W2024841180 countsByYear W20248411802013 @default.
• W2024841180 countsByYear W20248411802014 @default.
• W2024841180 countsByYear W20248411802015 @default.
• W2024841180 countsByYear W20248411802016 @default.
• W2024841180 countsByYear W20248411802019 @default.
• W2024841180 countsByYear W20248411802020 @default.
• W2024841180 countsByYear W20248411802023 @default.
• W2024841180 crossrefType "journal-article" @default.
• W2024841180 hasAuthorship W2024841180A5010073174 @default.
• W2024841180 hasAuthorship W2024841180A5030798280 @default.
• W2024841180 hasAuthorship W2024841180A5057478088 @default.
• W2024841180 hasBestOaLocation W20248411801 @default.
• W2024841180 hasConcept C126322002 @default.
• W2024841180 hasConcept C141071460 @default.
• W2024841180 hasConcept C142724271 @default.
• W2024841180 hasConcept C2776256026 @default.
• W2024841180 hasConcept C2777589429 @default.
• W2024841180 hasConcept C2777714996 @default.
• W2024841180 hasConcept C2778978224 @default.
• W2024841180 hasConcept C2779634585 @default.
• W2024841180 hasConcept C2910444461 @default.
• W2024841180 hasConcept C61434518 @default.
• W2024841180 hasConcept C71924100 @default.
• W2024841180 hasConceptScore W2024841180C126322002 @default.
• W2024841180 hasConceptScore W2024841180C141071460 @default.
• W2024841180 hasConceptScore W2024841180C142724271 @default.
• W2024841180 hasConceptScore W2024841180C2776256026 @default.
• W2024841180 hasConceptScore W2024841180C2777589429 @default.
• W2024841180 hasConceptScore W2024841180C2777714996 @default.
• W2024841180 hasConceptScore W2024841180C2778978224 @default.
• W2024841180 hasConceptScore W2024841180C2779634585 @default.
• W2024841180 hasConceptScore W2024841180C2910444461 @default.
• W2024841180 hasConceptScore W2024841180C61434518 @default.
• W2024841180 hasConceptScore W2024841180C71924100 @default.
• W2024841180 hasIssue "1" @default.
• W2024841180 hasLocation W20248411801 @default.
• W2024841180 hasLocation W20248411802 @default.
• W2024841180 hasOpenAccess W2024841180 @default.
• W2024841180 hasPrimaryLocation W20248411801 @default.
• W2024841180 hasRelatedWork W1986568177 @default.
• W2024841180 hasRelatedWork W2018347865 @default.
• W2024841180 hasRelatedWork W2024841180 @default.
• W2024841180 hasRelatedWork W2093801018 @default.
• W2024841180 hasRelatedWork W2099624476 @default.
• W2024841180 hasRelatedWork W2372561159 @default.
• W2024841180 hasRelatedWork W2415614775 @default.
• W2024841180 hasRelatedWork W2594353890 @default.
• W2024841180 hasRelatedWork W2767950643 @default.
• W2024841180 hasRelatedWork W99785324 @default.
• W2024841180 hasVolume "123" @default.
• W2024841180 isParatext "false" @default.
• W2024841180 isRetracted "false" @default.
• W2024841180 magId "2024841180" @default.
• W2024841180 workType "article" @default.